Yahoo
HKSE - Delayed Quote HKD

Chaoju Eye Care Holdings Limited (2219.HK)

2.360 0.000 (0.00%)
At close: October 30 at 4:08:06 PM GMT+8
Chart Range Bar
Loading chart for 2219.HK
  • Previous Close 2.360
  • Open 2.360
  • Bid 2.370 x --
  • Ask 2.380 x --
  • Day's Range 2.345 - 2.420
  • 52 Week Range 2.200 - 3.140
  • Volume 387,500
  • Avg. Volume 277,823
  • Market Cap (intraday) 1.615B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 8.74
  • EPS (TTM) 0.270
  • Earnings Date --
  • Forward Dividend & Yield 0.24 (10.27%)
  • Ex-Dividend Date May 14, 2026
  • 1y Target Est --

Chaoju Eye Care Holdings Limited, together with its subsidiaries, owns and operates a network of ophthalmic hospitals and centers in the People's Republic of China. The company offers in-patient and out-patient ophthalmic medical services; and consumer ophthalmic services, including treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia prevention and control. It also provides basic ophthalmic services for the treatment of a range of eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, dry eye syndrome, and oculoplastic and pediatric eye diseases. In addition, the company engages in investment management activities; and the sale of equipment, optical products, and medical consumables. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.

www.chaojueye.com

2,619

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2219.HK
6.19%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

2219.HK
0.80%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

2219.HK
26.67%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

2219.HK
60.01%
HANG SENG INDEX (^HSI)
8.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.98%

  • Return on Assets (ttm)

    4.55%

  • Return on Equity (ttm)

    6.81%

  • Revenue (ttm)

    1.37B

  • Net Income Avi to Common (ttm)

    164.52M

  • Diluted EPS (ttm)

    0.270

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.39B

  • Total Debt/Equity (mrq)

    10.67%

  • Levered Free Cash Flow (ttm)

    102.53M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: